Follicular Lymphoma Clinical Trials in Xiamen, Fujian
6 recruitingXiamen, Fujian, China
Showing 1–6 of 6 trials
Recruiting
Phase 3
A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma
Marginal Zone LymphomaRelapsed/Refractory Follicular Lymphoma
BeiGene780 enrolled277 locationsNCT05100862
Recruiting
Phase 3
A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma.
Refractory Follicular LymphomaFollicular LymphomaRelapsed/Refractory Follicular Lymphoma
Epizyme, Inc.612 enrolled229 locationsNCT04224493
Recruiting
Phase 2
Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL
DLBCL - Diffuse Large B Cell LymphomaFollicular Lymphoma
The First Affiliated Hospital of Xiamen University38 enrolled1 locationNCT06151080
Recruiting
Phase 2
Chidamide Combined With Linperlisibon for the Treatment of Refractory/Relapsed Follicular Lymphoma
Follicular LymphomaRefractory B-Cell Lymphoma
The First Affiliated Hospital of Xiamen University33 enrolled1 locationNCT06158386
Recruiting
Phase 2
Axicabtagene Ciloleucel Injection in Patients With Relapsed/Refractory Follicular Lymphoma
LymphomaFollicular LymphomaRefractory Lymphoma
The First Affiliated Hospital of Xiamen University30 enrolled1 locationNCT06826118
Recruiting
Phase 2
Zanubrutinib in Combination With Obinutuzumab (ZO) for Newly Diagnosed Follicular Lymphoma
Follicular LymphomaNewly Diagnosed
The First Affiliated Hospital of Xiamen University39 enrolled1 locationNCT06553352